FHI 360: Clinical Trials

11 trials sponsored by FHI 360, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 1 terminated, 1 unknown. 11 Phase 2, 4 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 211Completed 9, Terminated 1, Unknown 1
Phase 34Completed 4
Phase 11Unknown 1

Follow FHI 360: new trials by email

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Project Engage: Oral PrEP Acceptability
emtricitabine/tenofovir alafenamide, Emtricitabine / Tenofovir Disoproxil Oral Tablet - Acceptability of Health Care, Adherence, Medication
Phase 2CompletedEastern Virginia Medical School3302022-06-212024-07-29
A Safety and Immunogenicity Study of IVACFLU-A/H5N1
IVACFLU-A/H5N1 vaccine, Placebo - Avian Influenza
Phase 2 / Phase 3CompletedInstitute of Vaccines and Medical Biologicals, Vietnam9302017-03-072019-05-21
Community Intervention to Prevent Nipah Spillover
Ask people not to drink raw sap, Ask people not to drink sap or drink sap from skirt protected trees, No Intervention - Human NiV Infection
Phase 1 / Phase 2UnknownInternational Centre for Diarrhoeal Disease Research, Bangladesh77822012-11-102021-05-25
Implementation Effectiveness and Safety of Tenofovir Gel Provision Through Family Planning Services
1% tenofovir gel - HIV
Phase 2 / Phase 3CompletedCentre for the AIDS Programme of Research in South Africa3722012-10-012019-11-26
Comparison of the Shang Ring With Conventional Surgical Methods
Shang Ring, Male circumcision - Circumcision, Male
Phase 2 / Phase 3CompletedFHI 3604002011-02-012012-03-16
Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2
AIC316, Placebo - HSV-2
Phase 2CompletedAiCuris Anti-infective Cures AG1562010-03-012023-04-21
Contraceptive Effectiveness and Safety of the SILCS Diaphragm
SILCS Diaphragm, Nonoxynol-9 Gel, Buffer Gel - Contraception
Phase 2 / Phase 3CompletedCONRAD4502008-01-012018-03-16
Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV
Tenofovir gel, Placebo (Universal HEC placebo) - HIV Infections
Phase 2CompletedCentre for the AIDS Programme of Research in South Africa8892007-05-012016-02-01
Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV
Tenofovir Disoproxil Fumarate - HIV Infections
Phase 2CompletedFHI 36012002004-07-012006-08-01
Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission
Carraguard (PC-515) - HIV Infections, Chlamydia Trachomatis
Phase 2CompletedPopulation Council4001999-10-012017-08-14
Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV
Tenofovir Disoproxil Fumarate - HIV Infections
Phase 2TerminatedFHI 3605002006-02-10

Conditions studied

HIV Infections (4)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Henipavirus Infections (1)  ·  Influenza in Birds (1)  ·  Medication Adherence (1)  ·  Patient Acceptance of Health Care (1)  ·  Sexually Transmitted Diseases (1)  ·  Syphilis (1)  ·  Trichomonas Vaginitis (1)

Interventions

Tenofovir (3)  ·  Circumcision, Male (1)  ·  Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1)  ·  emtricitabine tenofovir alafenamide (1)  ·  pritelivir (1)

Countries

South Africa (4)  ·  United States (2)  ·  Bangladesh (1)  ·  Cameroon (1)  ·  Ghana (1)  ·  Kenya (1)  ·  Malawi (1)  ·  Nigeria (1)  ·  Vietnam (1)  ·  Zambia (1)  ·  Zimbabwe (1)

Top investigators

Quarraisha Abdool Karim, PhD (2)  ·  Alfred Poindexter, MD (1)  ·  Charlotte E. Ellertson, MPA, Ph.D. (1)  ·  David Archer, MD (1)  ·  Gustavo Doncel, MD,PhD (1)  ·  Homaira Hanif, PhD (1)  ·  Irving Hoffman, PA, MPH (1)  ·  Kurt Barnhart, MD (1)  ·  Leigh Peterson, PhD (1)  ·  Lynn Bradley, M.Sc. (1)  ·  Marc Goldstein, MD (1)  ·  Mitch M Creinin, MD (1)  ·  Ron Frezieres, MSPH (1)  ·  Tran N Duong, MD, PhD (1)

Results publications

PMID 20643915, PMID 21385354, PMID 22781225, PMID 23472071, PMID 23481666, PMID 24428466, PMID 25527071, PMID 25751199, PMID 26244306, PMID 28348164, PMID 31812464, PMID 33786810, PMID 36504254

NIH funding

R01AI045468 (1)